Direkt zum Inhalt
Merck
Alle Fotos(1)

Dokumente

BP1210

Ritonavir

British Pharmacopoeia (BP) Reference Standard

Synonym(e):

1,3-Thiazol-5-ylmethyl-N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)-methyl]-carbamoyl]-amino]-butanoyl]-amino]-1,6-diphenylhexan-2-yl]-carbamat

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C37H48N6O5S2
CAS-Nummer:
155213-67-5
Molekulargewicht:
720.94
UNSPSC-Code:
41116107

Qualität

pharmaceutical primary standard

Qualitätsniveau

100

Agentur

BP

API-Familie

ritonavir

Form

solid

Haltbarkeit

limited shelf life, expiry date on the label

Verpackung

pkg of 100 mg

Hersteller/Markenname

BP

Lagerbedingungen

dry at room temperature

Farbe

off-white

mp (Schmelzpunkt)

122-126  °C

Löslichkeit

ethanol: soluble
isopropanol: soluble
methanol: soluble

Dichte

1.239 g/cm3 at 20 °C

Anwendung(en)

pharmaceutical

Format

neat

Versandbedingung

ambient

Lagertemp.

2-8°C

InChI

1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1

InChIKey

NCDNCNXCDXHOMX-XGKFQTDJSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Verwandte Kategorien

Allgemeine Beschreibung

Ritonavir belongs to the group of protease inhibitors that are widely used in combination with other drugs in the prevention of HIV. Its mode of action involves binding to the active site of the protease enzyme and preventing the further maturation of new viral particles.
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Ritonavir BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:
  • Ritonavir Oral Solution
  • Ritonavir Tablets

    • Verpackung

    Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

    Sonstige Hinweise

    Sales restrictions may apply.

    Piktogramme

    Exclamation mark
    GHS07

    Signalwort

    Warning

    Gefahreneinstufungen

    Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral

    Lagerklassenschlüssel

    11 - Combustible Solids

    WGK

    WGK 3

    Flammpunkt (°F)

    Not applicable

    Flammpunkt (°C)

    Not applicable

    Choose from one of the most recent versions:

    Analysenzertifikate (COA)

    Lot/Batch Number

    Sorry, we don't have COAs for this product available online at this time.

    If you need assistance, please contact Kundensupport

    Besitzen Sie dieses Produkt bereits?

    In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

    Die Dokumentenbibliothek aufrufen

    RP-HPLC method development and validation for simultaneous estimation of Lopinavir and Ritonavir in tablet dosage form
    Bindu MJ, et al.
    International Journal of Science and Engineering Applications, 5(1), 77-77 (2017)
    HPTLC method for simultaneous determination of lopinavir and ritonavir in capsule dosage form
    Sulebhavikar VA, et al.
    Journal of Chemistry, 5(4), 706-712 (2008)

    Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

    Setzen Sie sich mit dem technischen Dienst in Verbindung.